José Valdez Madruga
José Valdez Madruga is a principal investigator at the Casa da Pesquisa do Centro de Referência em Treinamento para DST/AIDS in São Paulo, specializing in HIV and STIs, who has participated in clinical studies on lenacapavir and advocates for its effectiveness as a long-acting treatment option for individuals living with HIV.
Not in the pool (under ¢1).
Recent news mentions
José Valdez Madruga is the principal investigator of clinical studies at the Research House of the Reference Center for Training in STD/AIDS in São Paulo and has had an excellent experience with lenacapavir in clinical trials.
Anvisa aprova lenacapavir, 1ª injeção semestral revolucionária que previne a infecção em quase 100%
Brazil· 2026-01-12
José Valdez Madruga is the principal investigator of clinical studies at the Research House of the Reference Center for Training in STD/AIDS in São Paulo and has had an excellent experience with lenacapavir in clinical trials.
Anvisa aprova lenacapavir, 1ª injeção semestral revolucionária que previne a infecção em quase 100%Brazil· 2026-01-12